MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK
- PMID: 32982411
- PMCID: PMC7489953
- DOI: 10.2147/CMAR.S253777
MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK
Retraction in
-
MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK [Retraction].Cancer Manag Res. 2023 Jun 9;15:487-488. doi: 10.2147/CMAR.S424973. eCollection 2023. Cancer Manag Res. 2023. PMID: 37325187 Free PMC article.
Abstract
Background: Increasing evidence suggests that microRNAs (miRNAs) play critical roles in cancer progression. Therefore, investigating the function of miRNAs that are aberrantly expressed in gastric cancer (GC) and characterizing the involved underlying mechanism are essential for the treatment of gastric cancer. MiR-138-5p was found to be down-regulated in multiple cancers, which acted as a tumor suppressor in cancer progression; however, whether and how miR-138-5p regulates the malignant behaviors of GC has not been fully understood.
Methods: The level of miR-138-5p in GC tissues and cell lines was detected by RT-qPCR. The effects of miR-138-5p on the growth of GC cells were evaluated by the in vitro Cell Counting Kit-8 (CCK-8) assay, cell apoptosis, cell cycle analysis, wound-healing assay, and in vivo xenograft mice model. The targets of miR-138-5p were predicted using the miRDB online tool, confirmed by luciferase report assay and Western blot.
Results: MiR-138-5p was frequently decreased in GC tissues and cell lines. Decreased expression of miR-138-5p was significantly associated with the lymph node metastasis of GC patients. Overexpression of miR-138-5p suppressed GC cell proliferation, migration, increased cell apoptosis as well as inhibited the tumor growth in vivo. DEK oncogene was predicted as a potential target of miR-138-5p. MiR-138-5p bound the 3'-UTR of DEK and inhibited the level of DEK in GC cells. Restoration of DEK abrogated miR-138-5p overexpression-mediated suppression of GC cell proliferation and cell cycle arrest.
Conclusion: Our results demonstrated the anti-cancer role of miR-138-5p in GC by targeting DEK, which suggested miR-138-5p as a potential therapeutic target for the treatment of patient with GC.
Keywords: DEK; gastric cancer; miR-138-5p.
© 2020 Zhang et al.
Conflict of interest statement
The authors declare that there are no conflicts of interest regarding this paper.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7489953/bin/CMAR-12-8137-g0001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7489953/bin/CMAR-12-8137-g0002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7489953/bin/CMAR-12-8137-g0003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7489953/bin/CMAR-12-8137-g0004.gif)
Similar articles
-
Circular RNA circ_0000039 enhances gastric cancer progression through miR-1292-5p/DEK axis.Cancer Biomark. 2021;30(2):167-177. doi: 10.3233/CBM-201754. Cancer Biomark. 2021. PMID: 33104023
-
microRNA-524-5p inhibits proliferation and induces cell cycle arrest of osteosarcoma cells via targeting CDK6.Biochem Biophys Res Commun. 2020 Sep 24;530(3):566-573. doi: 10.1016/j.bbrc.2020.07.092. Epub 2020 Aug 1. Biochem Biophys Res Commun. 2020. PMID: 32747087
-
Regulation of cell proliferation and metastasis by microRNA-593-5p in human gastric cancer.Onco Targets Ther. 2018 Oct 24;11:7429-7440. doi: 10.2147/OTT.S178151. eCollection 2018. Onco Targets Ther. 2018. PMID: 30425531 Free PMC article.
-
MiR-129-5p inhibits proliferation of gastric cancer cells through targeted inhibition on HMGB1 expression.Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):3665-3673. doi: 10.26355/eurrev_202004_20829. Eur Rev Med Pharmacol Sci. 2020. PMID: 32329842
-
Downregulated miR-383-5p contributes to the proliferation and migration of gastric cancer cells and is associated with poor prognosis.PeerJ. 2019 Oct 15;7:e7882. doi: 10.7717/peerj.7882. eCollection 2019. PeerJ. 2019. PMID: 31637133 Free PMC article.
Cited by
-
miR-218-5p, miR-124-3p and miR-23b-3p act synergistically to modulate the expression of NACC1, proliferation, and apoptosis in C-33A and CaSki cells.Noncoding RNA Res. 2024 Feb 27;9(3):720-731. doi: 10.1016/j.ncrna.2024.02.016. eCollection 2024 Sep. Noncoding RNA Res. 2024. PMID: 38577025 Free PMC article.
-
Circ-Bptf Ameliorates Learning and Memory Impairments via the miR-138-5p/p62 Axis in APP/PS1 Mice.Mol Neurobiol. 2024 Mar 25. doi: 10.1007/s12035-024-04066-y. Online ahead of print. Mol Neurobiol. 2024. PMID: 38528305
-
MiR-138-5p Inhibits Thyroid Cancer Cell Growth and Stemness by Targeting TRPC5/Wnt/β-Catenin Pathway.Mol Biotechnol. 2024 Mar;66(3):544-553. doi: 10.1007/s12033-023-00782-3. Epub 2023 Jun 6. Mol Biotechnol. 2024. PMID: 37278959
-
Negative regulation of CD44st by miR-138-5p affects the invasive ability of breast cancer cells and patient prognosis after breast cancer surgery.BMC Cancer. 2023 Mar 24;23(1):269. doi: 10.1186/s12885-023-10738-0. BMC Cancer. 2023. PMID: 36964570 Free PMC article.
-
MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment.Cancers (Basel). 2023 Jan 29;15(3):824. doi: 10.3390/cancers15030824. Cancers (Basel). 2023. PMID: 36765782 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous